Next generation treatments to improve vision

Many diseases causing vision loss have few, or no, effective treatment options with many patients urgently seeking new alternatives. At the 2025 American Academy of Ophthalmology meeting, Marci English, Senior Vice President and Head of Biopharma and Ophthalmology Development at Astellas, shared insights on how innovative regenerative therapies, such as cell therapy for retinal diseases, may significantly improve vision for those affected. She also explored the role of cutting-edge science, along with strategic technological and manufacturing investments, in bringing these transformative therapies to fruition.